Evidence map›Paper›PMID 38929112›Full record

ArticleAntioxidants (Basel, Switzerland)2024

Ozone Therapy in the Integrated Treatment of Female Dogs with Mammary Cancer: Oxidative Profile and Quality of Life.

Laís Pereira Silva, Ricardo Wagner Portela, Marília Carneiro Machado, Gisele André Baptista Canuto, João Moreira Costa-Neto, Vitor de Moraes Pina de Carvalho, Hanna Carvalho de Sá, Karine Araújo Damasceno, Vinicius Ricardo Cuña de Souza, Clarisse Simões Coelho and 1 more

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Oxidative Stress in Canine Diseases: A Comprehensive Review.Antioxidants (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Laís Pereira SilvaResearch Center on Mammary Oncology (NPqOM), Federal University of Bahia, Salvador 40170-110, Brazil.
Ricardo Wagner PortelaLaboratory of Immunology and Molecular Biology (LABIMUNO), Institute of Health Sciences, Federal University of Bahia, Salvador 40110-100, Brazil.ORCID 0000-0001-9095-776X
Marília Carneiro MachadoResearch Center on Mammary Oncology (NPqOM), Federal University of Bahia, Salvador 40170-110, Brazil.
Gisele André Baptista CanutoDepartment of Analytical Chemistry, Institute of Chemistry, Federal University of Bahia, Salvador 40170-110, Brazil.ORCID 0000-0002-6616-3705
João Moreira Costa-NetoResearch Center on Mammary Oncology (NPqOM), Federal University of Bahia, Salvador 40170-110, Brazil.ORCID 0000-0003-2679-792X
Vitor de Moraes Pina de CarvalhoResearch Center on Mammary Oncology (NPqOM), Federal University of Bahia, Salvador 40170-110, Brazil.ORCID 0000-0003-3315-3807
Hanna Carvalho de SáDepartment of Analytical Chemistry, Institute of Chemistry, Federal University of Bahia, Salvador 40170-110, Brazil.
Karine Araújo DamascenoResearch Center on Mammary Oncology (NPqOM), Federal University of Bahia, Salvador 40170-110, Brazil.
Vinicius Ricardo Cuña de SouzaFaculty of Veterinary Medicine, Lusofona University, 1749-024 Lisbon, Portugal.ORCID 0000-0001-9041-7579
Clarisse Simões CoelhoFaculty of Veterinary Medicine, Lusofona University, 1749-024 Lisbon, Portugal.ORCID 0000-0003-2506-3510
Alessandra Estrela-LimaResearch Center on Mammary Oncology (NPqOM), Federal University of Bahia, Salvador 40170-110, Brazil.ORCID 0000-0002-9879-7999

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior PhD Fellowship to Lais SilvaNational Council for Scientific and Technological Development Research Fellowship to Alessandra Estrela (Proc. 310058/2022-8)National Council for Scientific and Technological Development Technological Development Fellowship to Ricardo Portela (Proc. 310058/2022-8)
6 · The paper itself

Abstract

Considering the high frequency of malignant breast tumors, there is a growing search for new therapeutic strategies that control neoplastic growth and dissemination, combined with fewer adverse reactions. Therefore, this study evaluated the effects of ozone therapy in female dogs with mammary cancer undergoing chemotherapy treatment. Twenty-five canines diagnosed with malignant mammary neoplasia were divided into two groups: one treated with carboplatin alone (

Indexed as

breast cancerchemotherapy-induced side effectsintegrative medicineozonereactive oxygen species

Identifiers

PMID38929112
PMCPMC11200475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.